Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.230
-0.130 (-5.51%)
At close: Aug 1, 2025, 4:00 PM
2.210
-0.020 (-0.90%)
After-hours: Aug 1, 2025, 7:52 PM EDT

Chimerix Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
7598953314191,851210
Upgrade
Market Cap Growth
-25.24%170.80%-21.16%-77.35%779.62%-
Upgrade
Enterprise Value
309357-284-2501,059256
Upgrade
Last Close Price
2.232.661.511.928.5011.70
Upgrade
PS Ratio
60.79113.71----
Upgrade
PB Ratio
1.811.930.550.642.480.98
Upgrade
P/TBV Ratio
1.831.950.550.642.480.98
Upgrade
EV/Sales Ratio
28.1645.39----
Upgrade
Debt / Equity Ratio
0.030.020.010.010.00-
Upgrade
Asset Turnover
0.020.01----
Upgrade
Quick Ratio
8.858.9144.0050.4145.4033.10
Upgrade
Current Ratio
9.019.0444.1150.7045.6233.69
Upgrade
Return on Equity (ROE)
-119.66%-106.27%-12.03%-14.87%-18.07%-25.03%
Upgrade
Return on Assets (ROA)
-23.33%-18.02%-9.64%-10.33%-11.21%-15.88%
Upgrade
Return on Capital (ROIC)
-25.08%-19.36%-9.84%-10.63%-11.61%-16.36%
Upgrade
Earnings Yield
-79.91%-63.44%-22.93%-24.85%-4.69%-19.79%
Upgrade
FCF Yield
-20.76%-14.59%-20.59%-23.01%-3.70%-17.43%
Upgrade
Buyback Yield / Dilution
-36.40%-22.79%-1.00%-9.52%-102.90%52.81%
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q